Table 2. Clinicopathological features of the patient with breast cancer.

ER, estrogen receptor; PR, progesterone receptor

Variables	Breast cancer
	n (%)
No of patients	40 (100)
Menopausal status
Premenopausal	20 (50)
Postmenopausal	20 (50)
Grade 1/2/3/4	2 (5) / 20 (50) / 14 (35) / 4 (10)
ER - / +	15 (37.5) / 25 (62.5)
PR - / +	21 (52.5) / 19 (47.5)
HER2 - / +	29 (72.5) / 11 (27.5)
Classification
Luminal	18 (45)
HER2+	11 (27.5)
Triple –	2 (5)
Triple +	9 (22.5)
Metastasis status
No	23 (57.5)
Yes	17 (42.5)